Recommended for Approval for the Same Indications as Herceptin® (Trastuzumab)
Positive Opinion for ABP 980 is Supported by Phase 3 Data in Patients With HER2-Postive Early Breast Cancer
PR Newswire
THOUSAND OAKS, Calif., March 23, 2018
PR Newswire
THOUSAND OAKS, Calif., March 23, 2018
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey